COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
Interview with Matthew J. Binnicker, PhD, on the potential negatives of resolving staffing shortages by using research scientists for clinical laboratory testing.
Four significant findings of a Kaiser Health News state antigen test survey.
Clinical laboratory leaders need to be aware of situations where COVID-19 antigen tests may be inadequate.
Points of interest from new UCLA-University of Washington research attempting to trace hospital patients’ symptoms to earlier than thought COVID-19 cases.
Continued coronavirus research will provide more robust data about the efficacy of CRISPR-based technology as a new diagnostic testing method.
Now an FDA EUA for Verily’s SARS-CoV-2 pooled testing that can test 12 samples at once—Google sister company’s clinical laboratory test leanings continue entry into market.
Interview with Matthew J. Binnicker, PhD, on the potential negatives of resolving staffing shortages by using research scientists for clinical laboratory testing.
Four significant findings of a Kaiser Health News state antigen test survey.
Clinical laboratory leaders need to be aware of situations where COVID-19 antigen tests may be inadequate.
Points of interest from new UCLA-University of Washington research attempting to trace hospital patients’ symptoms to earlier than thought COVID-19 cases.
Continued coronavirus research will provide more robust data about the efficacy of CRISPR-based technology as a new diagnostic testing method.
Now an FDA EUA for Verily’s SARS-CoV-2 pooled testing that can test 12 samples at once—Google sister company’s clinical laboratory test leanings continue entry into market.
